219 related articles for article (PubMed ID: 24293198)
1. The value of a QALY: individual willingness to pay for health gains under risk.
Bobinac A; van Exel J; Rutten FF; Brouwer WB
Pharmacoeconomics; 2014 Jan; 32(1):75-86. PubMed ID: 24293198
[TBL] [Abstract][Full Text] [Related]
2. GET MORE, PAY MORE? An elaborate test of construct validity of willingness to pay per QALY estimates obtained through contingent valuation.
Bobinac A; van Exel NJ; Rutten FF; Brouwer WB
J Health Econ; 2012 Jan; 31(1):158-68. PubMed ID: 22018622
[TBL] [Abstract][Full Text] [Related]
3. Willingness to pay for a quality-adjusted life-year: the individual perspective.
Bobinac A; Van Exel NJ; Rutten FF; Brouwer WB
Value Health; 2010 Dec; 13(8):1046-55. PubMed ID: 20825620
[TBL] [Abstract][Full Text] [Related]
4. A Contingent Valuation Study for Eliciting a Monetary Value of a Quality-Adjusted Life-Year in the General Greek Population.
Mavrodi A; Aletras V
Value Health Reg Issues; 2020 Sep; 22():36-43. PubMed ID: 32731168
[TBL] [Abstract][Full Text] [Related]
5. Valuing QALY gains by applying a societal perspective.
Bobinac A; van Exel NJ; Rutten FF; Brouwer WB
Health Econ; 2013 Oct; 22(10):1272-81. PubMed ID: 23080321
[TBL] [Abstract][Full Text] [Related]
6. The impact of the design of payment scales on the willingness to pay for health gains.
Soeteman L; van Exel J; Bobinac A
Eur J Health Econ; 2017 Jul; 18(6):743-760. PubMed ID: 27623946
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of willingness to pay per quality-adjusted life year for a cure: A contingent valuation method using a scenario-based survey.
Song HJ; Lee EK
Medicine (Baltimore); 2018 Sep; 97(38):e12453. PubMed ID: 30235732
[TBL] [Abstract][Full Text] [Related]
8. Estimating a WTP-based value of a QALY: the 'chained' approach.
Robinson A; Gyrd-Hansen D; Bacon P; Baker R; Pennington M; Donaldson C;
Soc Sci Med; 2013 Sep; 92():92-104. PubMed ID: 23849283
[TBL] [Abstract][Full Text] [Related]
9. Weighting and valuing quality-adjusted life-years using stated preference methods: preliminary results from the Social Value of a QALY Project.
Baker R; Bateman I; Donaldson C; Jones-Lee M; Lancsar E; Loomes G; Mason H; Odejar M; Pinto Prades JL; Robinson A; Ryan M; Shackley P; Smith R; Sugden R; Wildman J;
Health Technol Assess; 2010 May; 14(27):1-162. PubMed ID: 20525460
[TBL] [Abstract][Full Text] [Related]
10. Estimating a constant WTP for a QALY-a mission impossible?
Sund B; Svensson M
Eur J Health Econ; 2018 Jul; 19(6):871-880. PubMed ID: 28932914
[TBL] [Abstract][Full Text] [Related]
11. Comparing WTP values of different types of QALY gain elicited from the general public.
Pennington M; Baker R; Brouwer W; Mason H; Hansen DG; Robinson A; Donaldson C;
Health Econ; 2015 Mar; 24(3):280-93. PubMed ID: 25625510
[TBL] [Abstract][Full Text] [Related]
12. Willingness to pay for a QALY.
Gyrd-Hansen D
Health Econ; 2003 Dec; 12(12):1049-60. PubMed ID: 14673813
[TBL] [Abstract][Full Text] [Related]
13. Value of a QALY and VSI estimated with the chained approach.
Olofsson S; Gerdtham UG; Hultkrantz L; Persson U
Eur J Health Econ; 2019 Sep; 20(7):1063-1077. PubMed ID: 31172400
[TBL] [Abstract][Full Text] [Related]
14. Willingness to Pay for Health-Related Quality of Life Gains in Relation to Disease Severity and the Age of Patients.
Reckers-Droog V; van Exel J; Brouwer W
Value Health; 2021 Aug; 24(8):1182-1192. PubMed ID: 34372984
[TBL] [Abstract][Full Text] [Related]
15. Willingness to pay for a QALY based on community member and patient preferences for temporary health states associated with herpes zoster.
Lieu TA; Ray GT; Ortega-Sanchez IR; Kleinman K; Rusinak D; Prosser LA
Pharmacoeconomics; 2009; 27(12):1005-16. PubMed ID: 19908925
[TBL] [Abstract][Full Text] [Related]
16. A systematic review of studies eliciting willingness-to-pay per quality-adjusted life year: does it justify CE threshold?
Nimdet K; Chaiyakunapruk N; Vichansavakul K; Ngorsuraches S
PLoS One; 2015; 10(4):e0122760. PubMed ID: 25855971
[TBL] [Abstract][Full Text] [Related]
17. Estimating the monetary value of a Quality-Adjusted Life-Year in Quebec.
Kouakou CRC; He J; Poder TG
Eur J Health Econ; 2024 Jul; 25(5):787-811. PubMed ID: 37656261
[TBL] [Abstract][Full Text] [Related]
18. Sample restrictions and the elicitation of a constant willingness to pay per quality adjusted life year.
Nielsen JS; Gyrd-Hansen D; Kjaer T
Health Econ; 2021 May; 30(5):923-931. PubMed ID: 33569834
[TBL] [Abstract][Full Text] [Related]
19. Willingness to pay for QALY: perspectives and contexts in Japan.
Igarashi A; Goto R; Yoneyama-Hirozane M
J Med Econ; 2019 Oct; 22(10):1041-1046. PubMed ID: 31262236
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]